Cite
Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation
MLA
Kate E. Broderick, et al. “Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation.” Human Gene Therapy, vol. 30, Apr. 2019, pp. 523–33. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e18ca84e07c2b124461ef013c4afb08a&authtype=sso&custid=ns315887.
APA
Kate E. Broderick, Karuppiah Muthumani, Trevor R.F. Smith, Jacklyn Nguyen, Katherine Schultheis, Nina N. Schommer, Bryan S. Yung, David B. Weiner, & Laurent Humeau. (2019). Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation. Human Gene Therapy, 30, 523–533.
Chicago
Kate E. Broderick, Karuppiah Muthumani, Trevor R.F. Smith, Jacklyn Nguyen, Katherine Schultheis, Nina N. Schommer, Bryan S. Yung, David B. Weiner, and Laurent Humeau. 2019. “Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation.” Human Gene Therapy 30 (April): 523–33. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e18ca84e07c2b124461ef013c4afb08a&authtype=sso&custid=ns315887.